CANN GROUP LTD ORDINARY (CAN) Short Interest
CANN GROUP LTD ORDINARY (ASX:CAN) had 4.39% of shares reported as short positions as of 16 May 2026, representing 42,263,544 shares. CANN GROUP LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 4.39%
- Reported positions
- 42,263,544
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
CAN
Cann Group
Pharmaceuticals, Biotechnology & Life Sciences
Cann Group is an Australian pharmaceutical company focused on cultivating cannabis for medicinal and research purposes. They manufacture medicinal cannabis products, aiming to be a national benchmark for R&D and production processes. The company strives to improve the quality of life for patients through ethical leadership in the emerging medical cannabis industry.
Pharmaceuticals
Biotechnology
Medicinal Cannabis
ASX
Shorted
short percentage4.39%
reported shorts42.3M
shares on issue962.201M